We are proud to share the results of our recently published study on the Lepzi® PLGF test, now featured in Pregnancy Hypertension.

• Population: 503 pregnant women with suspected preeclampsia.
• Key Metrics:
• Negative Predictive Value: 96.9% for ruling out PE within 7 days.
• Sensitivity: 96.2%
• Specificity: 93.5%
• AUROC: 0.88, comparable to gold standard lab assays.

• Matches or outperforms lab-based diagnostics like DELFIA and Elecsys.
• Validated for both rule-in and rule-out of preterm pre-eclampsia.
• Offers decentralized testing with whole blood and no centrifugation required.
• Ideal for use in both high-resource hospitals and low-resource field settings.